Metastatic Pancreatic Cancer
Metastatic pancreatic cancer occurs when pancreatic cancer spreads from the pancreas to other parts of the body, often leading to serious health complications.
Ginisortamab for Advanced Pancreatic Cancer
We are studying the safety and effectiveness of ginisortamab combined with standard treatments for metastatic pancreatic cancer. This trial will help us understand how well it works and its potential side effects.
1-2 yearsEfficacy phase (II)Post-Trial Drug AccessNo PlaceboInvestigational MedicinesInjectionGastroenterologyOncology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a confirmed diagnosis of metastatic pancreatic cancer?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the last 3 months?
- Do you have significant heart or lung disease?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ginisortamab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Ulm AöR
Department of Internal Medicine I
Klingenstein, Germany
Klinikum rechts der Isar der TU Muenchen AöR
Department of internal medicine II
Munich, Germany
Oslo University Hospital HF
Medical Oncology
Oslo, Norway
Sponsor: Cancer Research UK
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.